指南与共识骨肿瘤

骨科肿瘤学中的争议

Controversies in orthopaedic oncology.
指南 / 共识 · Bone Joint J · 2024-05-01

2024年1月伯明翰骨科肿瘤会议(BOOM)汇集50多国300名代表,围绕软骨肉瘤的诊断、原发肿瘤治疗、亚型与并发症,以及肿瘤重建后假体周围感染(PJI)的两阶段翻修、抗生素预防、化疗患者急性PJI处理、伤口管理与同种异体骨重建等争议展开讨论,旨在形成共识并促进全球协作与研究。

要点

  • 软骨肉瘤是第二常见的手术治疗原发骨肉瘤,其诊断、原发肿瘤治疗、亚型及并发症仍存显著争议。
  • 肿瘤重建后假体周围感染(PJI)因辅助治疗、大范围暴露和手术复杂性而面临独特挑战。
  • 会议辩论了两阶段翻修、抗生素预防、化疗患者急性PJI处理及伤口管理与同种异体骨重建的最佳策略。

核心结论

  • 会议旨在基于证据整合与来自不同地理区域的专家意见形成共识声明,并促进全球协作与未来研究以解决未解难题。

研究设计与样本

  • 2024年1月伯明翰骨科肿瘤会议(BOOM)汇集来自50多个国家的300名代表,尝试达成全球共识。

主要发现

  • 软骨肉瘤是第二常见的手术治疗原发骨肉瘤,文献众多但诊断、原发肿瘤治疗、亚型及并发症仍存显著争议。
  • 肿瘤重建后假体周围感染(PJI)因辅助治疗、大范围暴露和手术复杂性而面临独特挑战。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of the primary tumour, subtypes, and complications. Therefore, consensus on its day-to-day treatment decisions is needed. In January 2024, the Birmingham Orthopaedic Oncology Meeting (BOOM) attempted to gain global consensus from 300 delegates from over 50 countries. The meeting focused on these critical areas and aimed to generate consensus statements based on evidence amalgamation and expert opinion from diverse geographical regions. In parallel, periprosthetic joint infection (PJI) in oncological reconstructions poses unique challenges due to factors such as adjuvant treatments, large exposures, and the complexity of surgery. The meeting debated two-stage revisions, antibiotic prophylaxis, managing acute PJI in patients undergoing chemotherapy, and defining the best strategies for wound management and allograft reconstruction. The objectives of the meeting extended beyond resolving immediate controversies. It sought to foster global collaboration among specialists attending the meeting, and to encourage future research projects to address unsolved dilemmas. By highlighting areas of disagreement and promoting collaborative research endeavours, this initiative aims to enhance treatment standards and potentially improve outcomes for patients globally. This paper sets out some of the controversies and questions that were debated in the meeting.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Jeys LM, Thorkildsen J, Kurisunkal V, et al. Controversies in orthopaedic oncology. Bone Joint J. 2024. PMID: 38689572. doi:10.1302/0301-620X.106B5.BJJ-2023-1381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。